Drugs need to loop through marketing.docVIP

 PAGE \* MERGEFORMAT 8 Drugs need to loop through marketing I reflect on the past few days has been the status of China’s pharmaceutical industry and found two strange phenomenon: First, China’s pharmaceutical market is not to finally pay or the interests of consumers as the core, but in the interests of-sale terminals as the core ; Second, the living conditions of pharmaceutical companies and the downstream bargaining power has nothing to do with the upper reaches of the Government as inversely proportional to the. I think this is a very strange phenomenon, because the formation of the dislocation of interest, the first phenomenon is the ‘foot the bill of sale terminals were robbed of money’, for the second phenomenon, this article not be discussed. We always say, ‘customer first’, but in the pharmaceutical industry, this is a luxury term. On what basis this conclusion? There are two reasons, one is system of medicine increases, one foot the bill’s ability to pay. Drugs increase the extent of the retail part of the largest Let us first discuss the first reason. Drugs increases system. Any of the pharmaceutical retail industry to understand that some people are aware that in fact ex-factory price of drugs is not high, mainly the role of the various components of the magnifying glass led to the ultimate high drug prices. After pharmaceutical factory after two increases in general areas: supply chain, retail link, circulation of the drug prices magnification are of different sizes, the key is the level of circulation of the number and level of competition; while the retail sector is the magnification of drug prices is the largest, Why do I say? The retail sector is magnified drug prices reflected in the following areas, first, into the cost of the terminal, and second, give the terminal deduction rate and the third is the recommendation of the terminal cost is for the terminal 4 of the annual / monthly Fandian, five is the terminal The period of reimbursement a